(Q34181930)

31 July 2017

1 reference

title

Respiratory syncytial virus prevention: past and present strategies (English)

1 reference

31 July 2017

Greenough A

1

1 reference

31 July 2017

Thomas M

series ordinal

2

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

Expert Opinion on Pharmacotherapy

31 July 2017

published in

1 reference

31 July 2017

volume

1

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

1195-1201

1 reference

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

Respiratory syncytial virus immunoglobulin and monoclonal antibodies in the prevention and treatment of respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

Respiratory syncytial virus immune globulin for prophylaxis against respiratory syncytial virus disease in infants and children with congenital heart disease. The Cardiac Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

Safety and pharmacokinetics of an intramuscular humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. The MEDI-493 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

Safety, tolerance and pharmacokinetics of a humanized monoclonal antibody to respiratory syncytial virus in premature infants and infants with bronchopulmonary dysplasia. MEDI-493 Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.1.6.1195

10.1517/14656566.1.6.1195

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference